Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma
Belamy B. Cheung*, Owen Tan, Jessica Koach, Bing Liu, Michael S Y Shum, Daniel R. Carter, Selina Sutton, Sela T. Po'uha, Louis Chesler, Michelle Haber, Murray D. Norris, Maria Kavallaris, Tao Liu, Geraldine M. O'Neill, Glenn M. Marshall
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
16
Link opens in a new tab
Citations
(Scopus)